Article
High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma
18 Jan 2022
Abstract excerpt
BACKGROUND: S100A2, a member of the S100 protein family, is abnormally expressed and plays a vital role in multiple cancers. However, little is known about the clinical significance of S100A2 in endometrial carcinoma. METHODS: Clinicopathological data were obtained from The Cancer Genome Atlas (TCGA), Genotype-Tissue Expression (GTEx), Gene Expression Omnibus (GEO), and Clinical Proteomic Tumor Analysis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
